Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts

NCT05761002 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05761002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05761002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts
Lead sponsor
Zagazig University
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2022
Completion date
July 1, 2023
Enrollment
58 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anogenital wart, human papilloma virus